Duke Personalized Health Blog

Precise But (Not Yet) Personal

Despite great advance in the field of personalized medicine and precision care therapies, there is still a dearth of progress in clinical models that use these emerging technologies to enhance preventive medicine. Precise But (Not Yet) Personal Ralph Snyderman President

Tagged with: , , ,

Obama to Request Research Funding for Treatments Tailored to Patients’ DNA

President Obama is seeking hundreds of millions of dollars to develop medical treatments tailored to the individual. Dr Snyderman offers his insight in the following NYTimes article regarding this precision medicine initiative. President Obama will seek hundreds of millions of

Tagged with: , ,

Industry Voices: Inside Genomics–Q&A with Bina CEO Narges Bani Asadi and Dr. Ralph Snyderman

By Narges Bani Asadi Published on FierceBiotech (http://www.fiercebiotech.com) January 24, 2014 One of the elements lacking in the personalized medicine discussion today is the perspective of leading clinicians, informaticists and academics working in the field. To remedy the gap, I’ve

Tagged with: , ,

Ten Years into Personalized Medicine: What We’ve Learned and What’s Next

Originally posted on Healthcommentary.org on January 17, 2014 Ten years ago, the sequencing of the entire human genome, along with the development of aggregate “omics” technologies began giving rise to a fundamentally new capability for the practice of medicine –

Tagged with: , ,

Personalized Health Care in 2013: A Status Report on the Impact of Genomics

The November/December 2013 issue of the NCMJ describes the impact that genomics has had on the practice of medicine in the decade since the full sequencing of the human genome was completed in 2003. Specifically, it reports on how genomics

Tagged with:

Personalized Health Care Drives Progress in Cancer

The American Society of Clinical Oncology is the leading professional organization committed to conquering cancer through research, education, prevention, and delivery of high quality patient care. Its Annual Meeting provides a forum where major advances in cancer are presented to

Tagged with: ,

Personalized Health Care: Science Provides Solutions

My interest in personalized health care began approximately a dozen years ago when as Chancellor for Health Affairs at Duke University, I realized that emerging sciences and technologies were creating medical capabilities never before known. Through the power of genomics,

Tagged with: , ,

P4 Medicine – How do we get from current practice to future progress?

In the current issue of Nature Reviews in Clinical Oncology, Stephen Friend and Leroy Hood – the man who first described predictive, personalized, preventive, and participatory medicine as “P4 medicine” emphasize that clinical trials of the future will need to

Tagged with: , ,

All the tests in the world don’t mean much without a plan

I recently spoke to a representative from the Indian Health Service about “personalized medicine” in federal initiatives. Of particular note, I mentioned during the course of our conversation that the Patient Protection and Affordable Care Act includes two stipulations for

Tagged with: , ,